All In Biotech

Free tool

FAERS Monitor: Purixan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205919 or its brand name (Purixan, Mercaptopurine). Reports on generic versions are filed under their own applications.

Reports

18,153

Serious

15,651

86% of reports

Hospitalization

8,092

Death reported

1,997

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • febrile neutropenia1,952
  • off label use1,399
  • pyrexia1,229
  • drug ineffective1,122
  • nausea825
  • vomiting796
  • abdominal pain724
  • diarrhoea721
  • neutropenia627
  • headache614
  • fatigue567
  • pneumonia541
  • crohn^s disease534
  • sepsis513
  • anaemia483

Reports by year received

View as table
YearReports
2004192
2005151
2006163
2007223
2008272
2009478
2010554
2011643
2012830
2013465
2014765
2015817
2016928
20171,156
20181,319
20191,277
20201,187
20211,379
20221,435
20231,287
20241,190
2025859
2026583

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,006 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal1,95235.133.662,927
neutropeniaSignal6275.45.02,225
sepsisSignal5135.34.91,811
pyrexiaSignal1,2294.13.92,946
abdominal painSignal7243.63.41,377
anaemiaSignal4832.92.7620
vomiting7962.01.8383
pneumonia5411.91.8248
off label use1,3991.91.8571
diarrhoea7211.31.249
nausea8251.21.130
headache6141.11.010
drug ineffective1,1221.00.90
fatigue5670.80.817
crohn^s disease5340.00.0617,665

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.